NCT01116648 2026-03-05Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast CancerNational Cancer Institute (NCI)Phase 1/2 Active not recruiting155 enrolled 34 charts
NCT05867251 2025-11-19Study of AVZO-021 in Patients With Advanced Solid TumorsAvenzo Therapeutics, Inc.Phase 1/2 Recruiting430 enrolled
NCT03519178 2025-11-14A Study of PF-06873600 in People With CancerPfizerPhase 1/2 Terminated155 enrolled 44 charts
NCT04442126 2025-05-23A Study of NM21-1480 in Adult Patients With Advanced Solid TumorsNumab Therapeutics AGPhase 1/2 Terminated52 enrolled 33 charts
NCT00182767 2016-03-10Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian CancerNational Cancer Institute (NCI)Phase 1/2 Completed45 enrolled 8 charts